Risk Stratification and Sudden Cardiac Death: Is It Time to Include Autonomic Variables?
Risk Stratification and Sudden Cardiac Death: Is It Time to Include Autonomic Variables?
复制标题
风险分层和心源性猝死:是时候纳入自主变量了吗?
DOI:
10.1161/circimaging.117.006819
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Vaseghi,Marmar
中科院分区:
文献类型:
--
作者:
Khakpour,Houman;Vaseghi,Marmar
2 Khakpour and Vaseghi Sympathetic Denervation and Sudden Cardiac Death (denervation, left ventricular end-diastolic volume index, and lack of angiotensin-converting enzyme inhibitor use; elevated BNP replaced elevated creatinine). Hence, a combination of sympathetic and myocardial remodeling seem to preferentially increase the risk of arrhythmic deaths in these patients. The extent of denervated myocardium, as assessed by positron emission tomography 11C-meta-hydroxyephedrine, is most likely a marker for heterogeneous sympathetic innervation, leading to increased dispersion of ventricular repolarization. Some of the same limitations that afflict retrospective studies apply to the current study. The studied population is small and predominantly men (90%). Certain variables, previously associated with mortality, including atrial fibrillation and chronic obstructive pulmonary disease, either were not collected or not included in the model given the population size and number of events. The limited number of patients also may potentially explain why variables such as left ventricular ejection fraction and New York Heart Association Class did not reach statistical significance for cardiac mortality, given their association with mortality in other studies. 15, 16 Furthermore, retrospective adjudication of cause-specific mortality and sudden cardiac arrest may be biased. There are also limitations with the quantification of defect size, which was based on using a 75% threshold for left ventricular maximum activity, a somewhat arbitrary threshold that can lead to inaccuracies if there exists a more global reduction in innervation, which has been shown in animal models of myocardial infarction and in patients with ischemic cardiomyopathy. 10, 11, 17 A regional retention index calculation or more standardized quantification across patients would have been valuable. Despite these limitations, Fallavollita et al are to be commended for their contribution, which points to the growing body of evidence supporting the inclusion of cardiac autonomic variables in assessing risk of SCD. This study, along with its predecessors, emphasize the need for incorporation of autonomic indices into risk stratification algorithms, in order to improve the prognostic ability of physicians to predict cause-specific mortality and to better allocate expensive resources and therapies, such as ICDs. Improved understanding of the mechanisms behind pathological cardiac sympathetic and parasympathetic innervation patterns also represent an important approach for future development of neuromodulatory therapies, some of which have already shown benefit in treatment of ventricular arrhythmias. 18 In this regard, future steps should include prospective validation of these autonomic variables, including sympathetic denervation, and implementation of randomized prospective studies aimed at modulating the cardiac autonomic nervous system for prevention of SCD.